Cited by 0Computational Drug Discovery MethodsMachine Learning in BioinformaticsProtein Degradation and Inhibitors

MultiRankDTA: A Hybrid Ranking Framework for Robust and Generalizable Drug-Target Affinity Prediction

Huang, Qiang, Wu, Yifan, Wang, Lin, Lin, Jianhui, Li, Yiming, Zeng, Min, Li, Min·2026·Journal of Chemical Information and Modeling

Abstract

Predicting drug-target affinity (DTA) is essential for screening candidate compounds in early-stage drug discovery. However, most existing computational methods formulate DTA prediction as a regression task, leading to an objective mismatch with the practical need to rank and prioritize candidate compounds based on their relative binding strengths. Moreover, existing ranking-based methods often adopt a fixed ranking objective or scoring function, which may limit their flexibility when they are applied to diverse drug-target interaction scenarios. To address these challenges, we propose MultiRankDTA, a novel framework that formulates DTA prediction as a multilevel ranking task to better align with the practical goal of drug screening. By integrating pointwise, pairwise, and listwise ranking strategies through a mixture-of-experts (MoE) module, MultiRankDTA enables dynamic and adaptive compound prioritization. Furthermore, we introduce a fusion network to reduce data set-specific biases by leveraging auxiliary supervision from multiple sources. Extensive experiments demonstrate that MultiRankDTA achieves superior performance compared to state-of-the-art computational methods across multiple benchmark data sets and delivers strong results on an independent benchmark for virtual screening, indicating its potential for generalization and practical utility. The source code can be obtained at https://github.com/CSUBioGroup/MultiRankDTA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jcim.6c00799

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Huang, Q., Wu, Y., Wang, L., Lin, J., Li, Y., Zeng, M., & Li, M.
Affiliations
  • Central South University (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Corresponding author
  • Zeng, Min
  • Li, Min
Venue
Journal of Chemical Information and Modeling
Published
2026-09-28
Volume
66
Issue
19
Pages
12291-12304
ISSN
  • 1549-9596 (ISSN-L)
  • 1549-960X
OpenAlex
W7214588855
Cited by
0
References
1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chemical Information and Modeling (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Central South University (1053320251390)
  • Natural Science Foundation of Hunan Province (2025JJ30025)
  • National Natural Science Foundation of China (62225209)
  • National Science and Technology Major Project (2026ZD0125300)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords
drug-target affinity prediction, mixture of experts, pairwise ranking, listwise ranking, compound prioritization, virtual screening, fusion network, early drug discovery
MeSH terms
Prediction Algorithms, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review